Hi Wasa, my reference to Cassava was to show that
a small bit of positive early stage small sample low scientific threshold AD results in the States
caused a tremendous gain in SP, got major NIH funding,
and is now a darling of independent investors.
If ACW’s more positive AD results and years of study and high potential impact across many dysfunctions were fully valued in the marketplace, I would be happier and there is no reason why ACW cannot be similarly aggressive and successful.
Hi Wasa, my reference to Cassava was to show thata small bit of...
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
